Modified paramagnetic nanoparticles for targeted delivery of therapeutics and methods thereof
AssigneeAlbert Einstein College of Medicine
InventorsJoel FRIEDMAN, Navati MAHANTESH
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlbert Einstein College of Medicine
InventorsJoel FRIEDMAN, Navati MAHANTESH
Estimating the term…
Described herein is a method of making modified paramagnetic nanoparticles with improved therapeutic loading efficiency and enhanced circulation properties. The method comprises coating a paramagnetic nanoparticle (PMNP) with a hydrophobic coating comprising lipophilic drug and a polymer. Also described herein is a PMNP, and a composition comprising PMNP. In certain embodiment, the PMNP have improved permeability through the blood brain barrier. Also described herein is a method of using the PMNP for the treatment of diseases. In certain embodiments, the method of treatment is a combination therapy. Described herein are imaging of therapeutic delivery of PMNP and diagnostic methods using the PMNP. Also described herein is a diagnostic kit that comprises the PMNP. The invention provides compositions comprising a paramagnetic nanoparticle having an external coating comprising a small organic molecule, a polymer, a blood protein, oleic acid, a lipophilic pharmaceutical or an allosteric effector of hemoglobin, as well as methods of making thereof, and use thereof in treatment and imaging.
A method of making modified PMNP comprising the steps of:
A method of making a modified PMNP comprising the steps of:
A method of making a drug-loaded albumin-coated paramagnetic nanoparticle (alb-PMNP) comprising the steps of:
A method of making modified PMNP comprising the steps of:
A modified paramagnetic nanoparticle (PMNP) comprising a PMNP core, which core comprises a coating, said coating comprising oleic acid, a fatty acid, albumin, or a combination thereof, said coating is dispersed therewith an allosteric effector of hemoglobin, curcumin, melanin, siRNA, plasmids, nitro fatty acids, adriamycin, taxol, or a combination thereof and wherein polymer PEG-DSPE are attached to the PMNP core.
Dependencies are inferred from the claim text.